Related Experiment Video
Updated: Jul 28, 2025

A Novel Method to Determine the Longitudinal Antibacterial Activity of Drug-Eluting Materials
Published on: March 3, 2023
Foot Osteomyelitis Caused by Multidrug- and Extensively Drug-Resistant Gram-Negative Bacteria
Efthymia Giannitsioti1, Christos Koutserimpas2, George Samonis3,4
1Osseous Infectious Diseases Department, "Attikon" General University Hospital, National and Kapodistrian University of Athens, School of Medicine, Athens, Greece, PC: 124 62.
Abstract:
There are scarce data regarding foot osteomyelitis (FO) caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria (GNB). This study investigates the causative organisms, the diagnostic and therapeutic approach and the outcome of these infections. All patients with FO caused by MDR and/or XDR GNB who received treatment in the Department of osseous infectious diseases of the "Attikon" University Hospital of Athens, Greece, were recorded and evaluated during a six-year-period. Seventeen patients, of which 64.7% females, with a mean age of 54.06 years were studied. There were nine cases with diabetic (DFO), and 76.5% of patients reported previous use of antimicrobials. Pathogens were isolated from soft-tissue biopsies or intra-operative tissue samples (n=12) and/or affected bone samples (n=5). In most cases, E. coli and P. aeruginosa were isolated (each 29.4%), followed by P. mirabilis (11.7%), while polymicrobial infection was detected in nine patients (53%). Most cases were given antimicrobial monotherapy (88.2%) with a mean duration of 90.05 days, while surgery significantly promoted cure of the infection. Foot and DFO cases represent a challenging to treat disease, requiring a multidisciplinary approach. Surgical treatment remains the cornerstone of treatment, while it is of utmost importance to isolate the causative organisms. MDR and XDR GNB represent an emerging threat and more data are needed to better understand these infections.
Insights
Foot osteomyelitis (FO) caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria (GNB) is challenging. Surgery combined with pathogen identification is crucial for treating these emerging infections.
Area of Science:
- Infectious Diseases
- Orthopedics
- Microbiology
Background:
- Foot osteomyelitis (FO) caused by multidrug-resistant (MDR) and extensively drug-resistant (XDR) Gram-negative bacteria (GNB) is poorly understood.
- This study evaluated 17 patients with FO due to MDR/XDR GNB over six years.
Discussion:
- Common pathogens included E. coli and P. aeruginosa, often in polymicrobial infections.
- Most patients received antimicrobial monotherapy, but surgical intervention significantly improved outcomes.
Key Insights:
- Diabetic foot osteomyelitis (DFO) was prevalent, with a history of prior antimicrobial use in most patients.
- Surgical treatment is the cornerstone for curing FO caused by MDR/XDR GNB.
Outlook:
- MDR and XDR GNB pose an emerging threat in FO, necessitating a multidisciplinary approach.
- Further research is required to better understand and manage these complex infections.
More Related Videos
18:40Combined In vivo Optical and µCT Imaging to Monitor Infection, Inflammation, and Bone Anatomy in an Orthopaedic Implant Infection in Mice
Published on: October 16, 2014
09:09Treatment with Vancomycin Loaded Calcium Sulphate and Autogenous Bone in an Improved Rabbit Model of Bone Infection
Published on: March 14, 2019
Related Concept Videos
Development of Antibiotic Resistance
Acute Pyelonephritis II: Diagnostic Studies and Management